| Product Code: ETC6755821 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Ustekinumab Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Ustekinumab Market Revenues & Volume, 2021 & 2031F |
3.3 China Ustekinumab Market - Industry Life Cycle |
3.4 China Ustekinumab Market - Porter's Five Forces |
3.5 China Ustekinumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Ustekinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Ustekinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic skin diseases such as psoriasis and atopic dermatitis in China |
4.2.2 Growing awareness among healthcare professionals and patients about ustekinumab's efficacy and safety |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from alternative treatment options such as biologics and traditional Chinese medicine |
5 China Ustekinumab Market Trends |
6 China Ustekinumab Market, By Types |
6.1 China Ustekinumab Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Ustekinumab Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Ustekinumab Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.4 China Ustekinumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2 China Ustekinumab Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Ustekinumab Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 China Ustekinumab Market Revenues & Volume, By Colitis, 2021- 2031F |
6.2.4 China Ustekinumab Market Revenues & Volume, By Lupus Erythematosus, 2021- 2031F |
6.2.5 China Ustekinumab Market Revenues & Volume, By Myositis Multiplex With Palmoplantar Pustulosis, 2021- 2031F |
6.2.6 China Ustekinumab Market Revenues & Volume, By Cirrhosis Of The Liver, 2021- 2031F |
6.2.7 China Ustekinumab Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.8 China Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 China Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
7 China Ustekinumab Market Import-Export Trade Statistics |
7.1 China Ustekinumab Market Export to Major Countries |
7.2 China Ustekinumab Market Imports from Major Countries |
8 China Ustekinumab Market Key Performance Indicators |
8.1 Patient adherence rate to ustekinumab treatment |
8.2 Number of healthcare professionals trained in prescribing ustekinumab |
8.3 Rate of new clinical trials and research studies on ustekinumab in China |
9 China Ustekinumab Market - Opportunity Assessment |
9.1 China Ustekinumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Ustekinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Ustekinumab Market - Competitive Landscape |
10.1 China Ustekinumab Market Revenue Share, By Companies, 2024 |
10.2 China Ustekinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here